We sought to characterise whether dexamethasone (DEX) may enhance tumour response to docetaxel in and types of metastatic prostate malignancy (Cover). A time-matched control without medication was also included. The supernatant was taken off the cells and centrifuged at 1000?g for 5?min to eliminate any cell particles as well as the supernatant was stored in… Continue reading We sought to characterise whether dexamethasone (DEX) may enhance tumour response